The Corona virus variant that was first discovered in South Africa is said to be able to avoid protection from vaccines Pfizer-BioNTech, according to a new study in Israel.
In research conducted by Tel Aviv University and Clalit, Israel’s largest healthcare provider, it was found that the South African virus could bypass the protection it offers. the COVID-19 vaccine Pfizer. This research was conducted on around 400 people who were positive for COVID-19 and had received vaccine shots and for 400 people who were vaccinated but not positive for COVID-19.
Quoted from CNBC International, researchers found that about 1 percent of South Africa’s B1351 variant was found in a number of COVID-19 cases studied. Furthermore, for those who had received two doses of the vaccine, the prevalence rate for the South African variant was eight times higher than for those who were not vaccinated – 5.4 percent versus 0.7 percent.
“This suggests the vaccine is less effective against the South African variant, compared to the original coronavirus and the variant first identified in the UK which includes nearly all COVID-19 cases in Israel,” the researchers said.
“We found higher rates of the South African variant among people vaccinated with the second dose, compared to the unvaccinated group. This means the South African variant can penetrate vaccine protection to some extent,” said Adi Stern of Tel Aviv University.
It’s just that the researchers warn that these results can not be used as a benchmark because it is only done with a limited sample.
Party Pfizer-BioNTech has not yet commented on these findings.
Watch Video “Starting today, here are the first coronavirus vaccinations in Singapore“
[Gambas:Video 20detik]
(kna/up)
– .
